Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 million; GraftAssure RUO assay launched July ...
BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today reported financial results ...
The news of the day as interpreted by our talented artists, illustrators and cartoonists.
🚗 Tesla sales fall in S.D. 🏢 DOGE targets S.D. offices Starlite reopening ⚾ Yu Darvish update 🪼 Jellyfish at SeaWorld Advocates and researchers have long complained that CalGang ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback